Showing results 1 to 2 of 2
Article
Rifaximin-alpha reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
Patel, Vishal C.
;
Lee, Sunjae
;
McPhail, Mark J. W.
;
et al
2022-02